JPS591414A - 少なくとも1種のポリフルオロ化されたアルコ−ルを含有する医薬 - Google Patents

少なくとも1種のポリフルオロ化されたアルコ−ルを含有する医薬

Info

Publication number
JPS591414A
JPS591414A JP58093889A JP9388983A JPS591414A JP S591414 A JPS591414 A JP S591414A JP 58093889 A JP58093889 A JP 58093889A JP 9388983 A JP9388983 A JP 9388983A JP S591414 A JPS591414 A JP S591414A
Authority
JP
Japan
Prior art keywords
formula
medicament
medicament according
component
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58093889A
Other languages
English (en)
Japanese (ja)
Inventor
エマヌエル・レビチ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARUFUATAIMU Ltd CO Inc
ETSUFUE CHI ENNE ETSUSE ERURE ERURE
FCN Srl
Original Assignee
ARUFUATAIMU Ltd CO Inc
ETSUFUE CHI ENNE ETSUSE ERURE ERURE
FCN Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARUFUATAIMU Ltd CO Inc, ETSUFUE CHI ENNE ETSUSE ERURE ERURE, FCN Srl filed Critical ARUFUATAIMU Ltd CO Inc
Publication of JPS591414A publication Critical patent/JPS591414A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/34Halogenated alcohols
    • C07C31/38Halogenated alcohols containing only fluorine as halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP58093889A 1982-05-28 1983-05-26 少なくとも1種のポリフルオロ化されたアルコ−ルを含有する医薬 Pending JPS591414A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8221553A IT8221553A0 (it) 1982-05-28 1982-05-28 Composizioni farmaceutiche adattivita' antineoplastica.
IT21553A/82 1982-05-28

Publications (1)

Publication Number Publication Date
JPS591414A true JPS591414A (ja) 1984-01-06

Family

ID=11183507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58093889A Pending JPS591414A (ja) 1982-05-28 1983-05-26 少なくとも1種のポリフルオロ化されたアルコ−ルを含有する医薬

Country Status (16)

Country Link
JP (1) JPS591414A (it)
AU (2) AU552557B2 (it)
BE (1) BE896838A (it)
CH (1) CH653890A5 (it)
DE (1) DE3319304A1 (it)
FR (1) FR2527439A1 (it)
GB (1) GB2121280B (it)
IE (1) IE55137B1 (it)
IL (1) IL68796A0 (it)
IN (1) IN157042B (it)
IT (1) IT8221553A0 (it)
LU (1) LU84827A1 (it)
NL (1) NL8301899A (it)
NZ (1) NZ204393A (it)
SE (1) SE8302976L (it)
ZA (1) ZA833871B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3836971C1 (it) * 1988-10-31 1990-05-17 Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3219004C1 (de) * 1982-05-19 1984-03-01 Philippine Dr. 8000 München Hartmann Arzneimittel zur Behandlung von Tumoren

Also Published As

Publication number Publication date
GB2121280B (en) 1985-08-29
GB2121280A (en) 1983-12-21
AU1500083A (en) 1983-12-01
NL8301899A (nl) 1983-12-16
IN157042B (it) 1986-01-04
IE55137B1 (en) 1990-06-06
AU552557B2 (en) 1986-06-05
IT8221553A0 (it) 1982-05-28
GB8314540D0 (en) 1983-06-29
BE896838A (nl) 1983-09-16
SE8302976L (sv) 1983-11-29
NZ204393A (en) 1986-03-14
SE8302976D0 (sv) 1983-05-26
IL68796A0 (en) 1983-09-30
DE3319304A1 (de) 1983-12-01
FR2527439A1 (fr) 1983-12-02
CH653890A5 (it) 1986-01-31
LU84827A1 (fr) 1983-11-17
ZA833871B (en) 1984-07-25
AU1557088A (en) 1988-11-10
IE831259L (en) 1983-11-28

Similar Documents

Publication Publication Date Title
TW386877B (en) Antitumour compositions containing taxane derivatives
Barrowman et al. Diarrhoeae in thyroid medullary carcinoma: role of prostaglandins and therapeutic effect of nutmeg.
JPH05500973A (ja) 化学的組成物
CA2286557A1 (en) Phorbol esters as anti-neoplastic agents
JPS625911A (ja) 骨の疾患を治療する方法
Hahn et al. Radioactive iron and its metabolism in anemia
US20130034617A1 (en) Gallium compositions for the treatment of liver cancer and methods of use
Bullard et al. Comparison of intravenous versus intracarotid therapy with 1, 3-bis (2-chloroethyl)-1-nitrosourea in a rat brain tumor model
Kondo et al. Production of metastases by treatment with carcinostatic agents I. Effects of carcinostatic agents on the host
Bjerkeset et al. Comparison of oral ftorafur and intravenous 5-fluorouracil in patients with advanced cancer of the stomach, colon or rectum
JPS6089434A (ja) ガンマ・インタ−フエロンおよびリンパ性毒素を含有する複合剤
JPS591414A (ja) 少なくとも1種のポリフルオロ化されたアルコ−ルを含有する医薬
Cyriax Epidural local anaesthesia
CN1200712C (zh) 用于治疗癌症的含喜树碱和1,2-二苯乙烯衍生物的组合物
Kennedy et al. Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma
EP3127544B1 (en) Anti-tumor drug containing anti-tumor platinum complex, and anti-tumor effect enhancer
Bliss et al. Effect of Sulfapyridine, Sulfathiazole and Sulfamethylthiazole upon Severe Staphylococcal Infection in Mice.
JPS5938207B2 (ja) 腎疾患治療剤
US3102844A (en) Oral iron-glucosamine hematinic composition and therapy
Kirsner et al. Effect of Dialyzed Enterogastrone Upon Twelve-Hour Nocturnal Gastric Secretion in Man.
JPH0211513A (ja) 制癌剤
Killen et al. Phase II studies of methyl glyoxal bis‐guanylhydrazone (NSC 32946) in carcinoma of the colon and lung
NEAL et al. EFFECT OF ACTH, CORTISONE, AND DOCA® ON SURVIVAL OF BURNED RAT
JPH0534338B2 (it)
CN112546048A (zh) HKL-5-61与Osimertinib的药物组合及其应用